Immunization of mice with the dengue 2 virus (DEN 2)-specified non-structural protein NS1 provided significant protection against intracerebral challenge with the virus in the absence of detectable neutralizing or other anti-virion antibody. NS1, purified from lysates of infected Vero cells by immunoaffinity chromatography, expressed an antigenic site(s) common to each of the four DEN serotypes, and hyperimmunization of rabbits with NS1 stimulated production of complement-fixing (CF) antibody with broad DEN serotype specificity. However, cross-protection was not observed: mice immunized with DEN 2 NS1 developed little or no heterologous CF antibody and were not protected against challenge with neurovirulent DEN 1. Induction of a protective immune response by NS1 suggests that it be considered for incorporation into possible synthetic or recombinant DNA DEN vaccines.
BancroftW. H., ScottR. McN., EckelsK. H., HokeC. H.JrSimmsT. E., JesraniK. D. T., SummersP. L., DuboisD. R., TsoulosD, RussellP. K.1984; Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. Journal of Infectious Diseases 149:1005–1010
CaseyH. L.1965; Standardized diagnostic complement-fixation method and adaptation to micro test. Public Health Monograph No. 74 U.S. Public Health Service Publication 1228
EckelsK. H., ScottR. McN., BancroftW. H., BrownJ., DuboisD. R., SummersP. L., RussellP. K., HalsteadS. B.1984; Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fet al rhesus lung cells. American Journal of Tropical Medicine and Hygiene 33:684–689
GentryM. K., HenchalE. A., McCownJ. M., BrandtW. E.1982; Identification of distinct antigenic determinants on dengue-2 virus by using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 33:548–555
RiceC. M., LenchesE. M., EddyS. R., ShinS. J., SheetsR. L., StraussJ. H.1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
RussellP. K., ChiewslipD., BrandtW. E.1970; Immunoprcipitation analysis of soluble complement-fixing antigens of dengue viruses. Journal of Immunology 105:838–845
SchlesingerJ. J., BrandrissM. W., WalshE. E.1985; Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135:2805–2809
SchlesingerJ. J., BrandrissM. W., CroppC. B., MonathT. P.1986; Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural NS1. Journal of Virology 60:1153–1155
SchlesingerR. W., GordonI., FrankelJ. W., WinterJ. W., PattersonP. R., DorranceW. R.1956; Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses. Journal of Immunology 77:352–364
SmithG. W., WrightP. J.1985; Synthesis of proteins and glycoproteins in dengue type 2 virus-infected Vero and Aedes albopictus cells. Journal of General Virology 66:559–571